Testing new treatments for thyroid cancer

Full project name: Targeting intracellular innate immune signalling in head and neck and thyroid cancers

Tag: New treatment

<strong>Tag:</strong> New treatment
Dr Malin Pedersen
Dr Malin Pedersen

Project type:
Project

Project Leader:
Prof Kevin Harrington

Researcher:
Dr Malin Pedersen

Commencement date:
October 2018

Length of project:
1 year

Funding provided:
£115,784

Funder:

Location:
Institute of Cancer Research

The problem

The incidence of thyroid cancer is growing at a faster rate than any other malignancy, with more women than men being affected. Particular subgroup types of thyroid cancer are highly aggressive and frequently lethal. For these patients, there are few available effective treatment options.

The research
The future
Institute of Cancer Research
Institute of Cancer Research

Help fund this project

For more information on funding this project specifically please email us

Donate now and together we can save more lives by beating cancer sooner.

Follow us

Get in touch

Call 0203 475 3471

Email info@oraclecancertrust.org

Registered-logos-grey

Oracle Cancer Trust is a registered charity in England and Wales (1142037). A company limited by guarantee. Registered company in England and Wales (7125497). Registered address: 80 Coombe Road, New Malden KT3 4QS